Jonsson Comprehensive Cancer Center

The center was originated by UCLA scientists and volunteers who began working together in the late 1960s.[http://www.cancer.gov/research/nci-role/cancer-centers/find/uclajonsson Jonsson Comprehensive Cancer Center: University of California at Los Angeles, Los Angeles, California], National Cancer Institute (accessed August 22, 2016). The center was formally established in 1974 and was designated as a comprehensive cancer center by the National Cancer Institute in 1976.Anne Hubell, "University of California, Los Angeles, Jonsson Comprehensive Cancer Center" in The SAGE Encyclopedia of Cancer and Society (SAGE Publications: 2d ed. 2015; ed. Graham A. Colditz), pp. 1228-29. The namesake of the center is the Jonsson family; entrepreneur and philanthropist Kenneth Alan Jonsson (the son of Texas Instruments co-founder J. Erik Jonsson), along with his wife Diana Gordon Jonsson, made a $1 million gift for UCLA in 1975 to establish the center, and continued to financially support the center over a period of decades.[https://www.latimes.com/local/obituaries/la-me-kenneth-jonsson4-2010apr04-story.html Obituary: Kenneth Alan Jonsson dies at 79; co-founder of cancer center at UCLA], Los Angeles Times (April 4, 2010).Mary Rourke, [https://www.latimes.com/archives/la-xpm-2006-may-12-me-jonsson12-story.html Diana G. Jonsson, 76; Helped Found Prominent Cancer Center at UCLA], Los Angeles Times (May 12, 2006).

Joseph W. Cullen served as a deputy director of the center.[https://www.nytimes.com/1990/11/28/obituaries/joseph-w-cullen-53-a-cancer-researcher.html Obituary: Joseph W. Cullen, 53, a Cancer Researcher], New York Times (November 28, 1990).

The primary sponsor of the center is the Jonsson Cancer Center Foundation (JCCF), a 501(c)(3) entity (established in 1945).[http://www.cancer.ucla.edu/about-us/about-the-jonsson-cancer-center-foundation About the Jonsson Cancer Center Foundation], Jonsson Comprehensive Cancer Center (accessed August 22, 2016).

The center employs over 500 physicians and scientists, who engage in clinical activities (i.e., cancer treatment), education, research (basic and clinical), and cancer prevention.{{cite web|url=https://cancer.ucla.edu/about-us/a-comprehensive-cancer-center|title=UCLA Jonsson Comprehensive Cancer Center : A Comprehensive Cancer Center|website=cancer.ucla.edu}}

Although based at UCLA, the center has clinics elsewhere in California, in Westwood, Santa Monica, Alhambra, Irvine, Pasadena, Porter Ranch, Santa Clarita, and Simi Valley.

The center is known for its research on breast and ovarian cancer. JCCC scientists developed palbociclib (PD 0332991), a breast-cancer drug that was in phase III clinical trials as of 2015. JCCC scientists also identified IGF-1 as a pathway as one pathway for the growth of tumors.

In 2013, U.S. News & World Report ranked JCCC as #11 nationally among cancer centers. In 2015, the center ranked #6.[http://www.cancer.ucla.edu/Home/Components/News/News/836 UCLA's Jonsson Comprehensive Cancer Center once again ranks among top 10 cancer centers nationwide] (press release), Jonsson Comprehensive Cancer Center (July 21, 2015).

In 2023, U.S. News & World Report ranked JCCC #4 nationally and #1 in California among cancer centers.{{Cite web |last=Harder |first=Ben |date=August 1, 2023 |title=America's Best Hospitals: the 2023-2024 Honor Roll and Overview |url=https://health.usnews.com/health-care/best-hospitals/articles/best-hospitals-honor-roll-and-overview}}

{{reflist}}

• {{Official website|http://www.cancer.ucla.edu }}

{{UCLA Health}}

{{DEFAULTSORT:Jonsson Comprehensive Cancer Center}}

Category:University of California, Los Angeles

Category:Cancer organizations based in the United States

Category:NCI-designated cancer centers

Category:UCLA Health